• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email
    SC 13G/A 1 d390439dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

     

    Pineapple Energy Inc.

    (Name of Issuer)

    Common Stock, $0.05 par value per share

    (Title of Class of Securities)

    72303P107

    (CUSIP Number)

    September 28, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 72303P107    13G            

     

      1.    

      Names of Reporting Persons

     

      Hercules Capital, Inc.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☐

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Maryland

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5.    

      Sole Voting Power

     

      304,485

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      304,485

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      304,485

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

       ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      4.1%

    12.  

      Type of Reporting Person (See Instructions)

     

      CO


    Item 1.

     

      (a)

    Name of Issuer:

    Pineapple Energy Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    10900 Red Circle Drive

    Minnetonka, MN 55343

    Item 2.

     

      (a)

    Name of Person Filing:

    Hercules Capital, Inc.

     

      (b)

    Address of Principal Business Office or, if None, Residence:

    400 Hamilton Avenue, Suite 310

    Palo Alto, CA 94301

     

      (c)

    Citizenship:

    Maryland

     

      (d)

    Title of Class of Securities:

    Common Stock, par value of $0.05 per share

     

      (e)

    CUSIP Number:

    72303P107

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)    ☐    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
    (j)    ☐    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
    (k)    ☐    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    3


    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    Item 4.

    Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a)

    Amount beneficially owned:    

    304,485

     

      (b)

    Percent of class:    

    4.1% of the 7,435,586 shares outstanding as reported in the Issuer’s Registration Statement on Form S-3 filed on August 15, 2022.

     

      (c)

    Number of shares as to which the person has:

     

      (i)

    Sole power to vote or to direct the vote:    

    304,485

     

      (ii)

    Shared power to vote or to direct the vote:    

    0

     

      (iii)

    Sole power to dispose or to direct the disposition of:    

    304,485

     

      (iv)

    Shared power to dispose or to direct the disposition of:    

    0

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not Applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not Applicable

     

    Item 9.

    Notice of Dissolution of Group.

    Not Applicable


    Item 10.

    Certifications.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: October 12, 2022

     

    HERCULES CAPITAL, INC.
    Signed:  

    /s/ Kiersten Zaza Botelho

    Name:   Kiersten Zaza Botelho
    Title:   General Counsel, Chief Compliance Officer and Secretary
    Get the next $HTGC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    3/13/2023$14.50 → $10.50Mkt Perform → Underperform
    Keefe Bruyette
    7/29/2022Outperform → Perform
    Oppenheimer
    More analyst ratings

    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company's diversified investment portfolio with a focus on senior secured first lien venture debt investments in the technology

    8/19/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    SEC Filings

    View All

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:30:57 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hercules Capital Inc.

    10-Q - Hercules Capital, Inc. (0001280784) (Filer)

    7/31/25 4:17:31 PM ET
    $HTGC
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Hercules Capital Inc.

    SCHEDULE 13G/A - Hercules Capital, Inc. (0001280784) (Subject)

    7/8/25 2:09:57 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer & CCO Botelho Kiersten Zaza covered exercise/tax liability with 770 shares, decreasing direct ownership by 1% to 65,881 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:48 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Operating Officer Follmann Christian covered exercise/tax liability with 829 shares, decreasing direct ownership by 0.69% to 119,423 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:28 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Financial Officer Meyer Seth H covered exercise/tax liability with 4,051 shares, decreasing direct ownership by 1% to 377,121 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/15/25 5:03:12 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Follmann Christian sold $7,043 worth of shares (395 units at $17.83) and bought $7,043 worth of shares (395 units at $17.83), increasing direct ownership by 0.22% to 121,212 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/5/25 6:38:34 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Theodosopoulos Nikos bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 101% to 11,960 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:23 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Loo Wade bought $104,923 worth of shares (5,999 units at $17.49), returned 5,645 shares to the company and was granted 5,645 shares, increasing direct ownership by 5% to 7,504 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    5/9/25 4:22:04 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hercules Capital upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

    12/12/24 8:09:58 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital downgraded by Compass Point with a new price target

    Compass Point downgraded Hercules Capital from Buy to Neutral and set a new price target of $17.50 from $17.00 previously

    1/16/24 8:29:29 AM ET
    $HTGC
    Investment Managers
    Finance

    UBS initiated coverage on Hercules Capital with a new price target

    UBS initiated coverage of Hercules Capital with a rating of Neutral and set a new price target of $17.00

    11/21/23 7:31:43 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Leadership Updates

    Live Leadership Updates

    View All

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    11/29/23 1:01:00 PM ET
    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Financials

    Live finance-specific insights

    View All

    Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

    CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

    8/8/25 7:45:00 AM ET
    $HRTX
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Hercules Capital Reports Second Quarter 2025 Financial Results

    Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

    7/31/25 4:07:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our website at inves

    7/17/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    5/8/23 5:06:26 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)

    4/27/22 4:31:08 PM ET
    $HTGC
    Investment Managers
    Finance